These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27446553)

  • 21. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial.
    Biniaz V; Tayebi A; Ebadi A; Sadeghi Shermeh M; Einollahi B
    Iran J Kidney Dis; 2014 Sep; 8(5):401-7. PubMed ID: 25194408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors.
    Goldfarb DS; MacDonald PA; Hunt B; Gunawardhana L
    J Rheumatol; 2011 Jul; 38(7):1385-9. PubMed ID: 21572152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.
    Waldman B; Ansquer JC; Sullivan DR; Jenkins AJ; McGill N; Buizen L; Davis TME; Best JD; Li L; Feher MD; Foucher C; Kesaniemi YA; Flack J; d'Emden MC; Scott RS; Hedley J; Gebski V; Keech AC;
    Lancet Diabetes Endocrinol; 2018 Apr; 6(4):310-318. PubMed ID: 29496472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects.
    Shen Z; Gillen M; Miner JN; Bucci G; Wilson DM; Hall JW
    Drug Des Devel Ther; 2017; 11():2077-2086. PubMed ID: 28744099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice.
    Kodithuwakku ND; Feng YD; Zhang YY; Pan M; Fang WR; Li YM
    J Ethnopharmacol; 2015 Apr; 163():278-89. PubMed ID: 25614106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study.
    Hosoya T; Sasaki T; Ohashi T
    Clin Rheumatol; 2017 Mar; 36(3):649-656. PubMed ID: 27832384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.
    Gunawardhana L; Becker MA; Whelton A; Hunt B; Castillo M; Saag K
    Arthritis Res Ther; 2018 May; 20(1):99. PubMed ID: 29848361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.
    Dalbeth N; Saag KG; Palmer WE; Choi HK; Hunt B; MacDonald PA; Thienel U; Gunawardhana L
    Arthritis Rheumatol; 2017 Dec; 69(12):2386-2395. PubMed ID: 28975718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action.
    Cheng LC; Murugaiyah V; Chan KL
    J Ethnopharmacol; 2015 Dec; 176():485-93. PubMed ID: 26593216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
    Würzner G; Gerster JC; Chiolero A; Maillard M; Fallab-Stubi CL; Brunner HR; Burnier M
    J Hypertens; 2001 Oct; 19(10):1855-60. PubMed ID: 11593107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial.
    Huang HY; Appel LJ; Choi MJ; Gelber AC; Charleston J; Norkus EP; Miller ER
    Arthritis Rheum; 2005 Jun; 52(6):1843-7. PubMed ID: 15934094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
    Cutolo M; Cimmino MA; Perez-Ruiz F
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acupuncture for serum uric acid in patients with asymptomatic hyperuricemia: A randomized, double-blind, placebo-controlled trial.
    Huang Y; Meng J; Sun B; Xiang T; Zhou X; Xu B; Wu Y; Chen Z; Zhang S
    Int J Cardiol; 2017 Apr; 232():227-232. PubMed ID: 28087178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia.
    Usharani P; Nutalapati C; Pokuri VK; Kumar CU; Taduri G
    Clin Pharmacol; 2016; 8():51-9. PubMed ID: 27382337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout.
    Poiley J; Steinberg AS; Choi YJ; Davis CS; Martin RL; McWherter CA; Boudes PF;
    Arthritis Rheumatol; 2016 Aug; 68(8):2027-34. PubMed ID: 26989892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihyperuricemic properties of amflutizole in gout.
    Wortmann RL; Ridolfo AS; Lightfoot RW; Fox IH
    J Rheumatol; 1985 Jun; 12(3):540-3. PubMed ID: 3900392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
    Garg JP; Chasan-Taber S; Blair A; Plone M; Bommer J; Raggi P; Chertow GM
    Arthritis Rheum; 2005 Jan; 52(1):290-5. PubMed ID: 15641045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial.
    Stamp LK; O'Donnell JL; Frampton C; Drake JM; Zhang M; Chapman PT
    Arthritis Rheum; 2013 Jun; 65(6):1636-42. PubMed ID: 23681955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.